Sign In  |  Register  |  About Sunnyvale  |  Contact Us

Sunnyvale, CA
September 01, 2020 10:10am
7-Day Forecast | Traffic
  • Search Hotels in Sunnyvale

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against UiPath Inc. (PATH)

The law firm of Kirby McInerney LLP is investigating potential claims against UiPath Inc. (“UiPath” or the “Company”) (NYSE: PATH). The investigation concerns whether UiPath and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

[Click here to learn more about the investigation]

On May 29, 2024, UiPath announced that Rob Enslin, the Company’s CEO and a member of its board of directors was resigning from his positions effective June 1, 2024, to be replaced by former CEO Daniel Dines. On this news, the price of UiPath shares declined by $6.23 per share, or approximately 34%, from $18.30 per share on May 29, 2024 to close at $12.07 on May 30, 2024.

If you purchased or otherwise acquired UiPath securities, have information, or would like to learn more about this investigation, contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or by filling out this CONTACT FORM, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Sunnyvale.com & California Media Partners, LLC. All rights reserved.